1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea has been researched along with Abnormalities, Autosome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellman, M; Gunnarsson, PO; Hansen, HH; Hansson, K; Hartley-Asp, B; Polacek, J; Vibe-Petersen, J | 1 |
| Hartley-Asp, B | 1 |
2 other study(ies) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Abnormalities, Autosome
| Article | Year |
|---|---|
Chromosome aberrations and pharmacokinetics in patients receiving tauromustine as either a single or a repeated dose.
Topics: Antineoplastic Agents; Chromosome Aberrations; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Lung Neoplasms; Nitrosourea Compounds; Taurine | 1996 |
Genotoxicity of tauromustine, a new water soluble taurine-based nitrosourea. I. Mutagenic and clastogenic activity of tauromustine in vitro.
Topics: Antineoplastic Agents; Cell Cycle; Chromosome Aberrations; Humans; In Vitro Techniques; Lomustine; Lymphocytes; Mutagenicity Tests; Mutagens; Nitrosourea Compounds; Salmonella typhimurium; Sister Chromatid Exchange; Taurine | 1992 |